This inventor holds 1 USPTO granted patent. Top assignee: Sciclone Pharmaceuticals, Inc.. Active years: 1994.
Company Filing History:
Years Active: 1994
Title: Bruce F. Scharschmidt: Innovator in Hepatitis B Treatment
Introduction
Bruce F. Scharschmidt is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of hepatitis B. His innovative approach has the potential to improve the lives of many individuals affected by this condition.
Latest Patents
Scharschmidt holds a patent for a method aimed at treating hepatitis B carriers with minimal disease. The patent, titled "Method for treating hepatitis B carriers with minimal disease," discloses methods for treating minimal disease hepatitis B infection. In this approach, minimal disease carriers are administered thymosin .alpha.-1, or biologically active fragments or analogs thereof. This treatment method aims to reduce or eliminate the indications of hepatitis B.
Career Highlights
Bruce F. Scharschmidt is associated with Sciclone Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in the field of medical advancements.
Collaborations
One of his notable coworkers is John D. Baxter, with whom he has likely collaborated on various projects related to hepatitis B treatment and other medical innovations.
Conclusion
In summary, Bruce F. Scharschmidt is a distinguished inventor whose work in hepatitis B treatment showcases his commitment to improving healthcare outcomes. His innovative methods and collaborations highlight the importance of research in addressing medical challenges.